Safety and Efficacy of Elobixibat in Constipation - Echo 1

• Research type

  Research Study

• Full title

  A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients with Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks

• IRAS ID

  125766

• Contact name

  Robin Spiller

• Contact email

  robin.spiller@nottingham.ac.uk

• Sponsor organisation

  Ferring International Pharmascience Center US, Inc

• Eudract number

  2012-005587-94

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  East Midlands - Nottingham 2 Research Ethics Committee

• REC reference

  13/EM/0136

• Date of REC Opinion

  26 Apr 2013

• REC opinion

  Favourable Opinion